Abstract Juvenile Idiopathic Arthritis (JIA) represents a diverse group of chronic inflammatory
conditions that begin in childhood or adolescence and continue into adulthood, with varying …

Objective To study juvenile idiopathic arthritis (JIA) long‐term outcomes in relation to the
time of initiation of biologic disease‐modifying antirheumatic drug (bDMARD). Methods …

Objective The objective of this study was to examine the incidence and accumulated burden
of psychiatric disorders in juvenile idiopathic arthritis (JIA) relative to the general population …

Promising candidate tools for predicting disease severity and long-term remission in juvenile
arthritis are now available. These tools need external validation in other populations, and …

Objectives To evaluate the feasibility and preliminary effectiveness of iCanCope with Pain
(iCanCope), a smartphone-based pain self-management program, in adolescents with JIA …

Objectives To compare real-world effectiveness of two adaptive treatment strategies of
disease-modifying antirheumatic drugs (DMARDs) in treating children with newly diagnosed …

Objectives To investigate the courses and outcomes of pregnancies involving JIA patients
who were exposed to DMARDs. Methods In the Juvenile arthritis MTX/Biologics long-term …

Objective To assess the medication and disease burden of young adults with juvenile
idiopathic arthritis (JIA). Methods Young adults with JIA prospectively followed in the …

This retrospective case–control study compared inflammatory and structural damage in the
temporomandibular joint of patients with juvenile idiopathic arthritis (JIA) and its subtypes …

Background Most childhood-onset rheumatic diseases are chronic health conditions, which
need long-term care throughout adulthood. A well-organized transition care is challenging …